Barclays Capital today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to overweight (from equal weight) and raised its price target to 2800p (from...
Network infrustructure company CyanConnode reported narrower losses, but lower revenue as orders were hurt by the impact from the pandemic and the elections in India....
Capital & Regional said it would keep its dividend suspended until markets stabilised after the real estate investment trust reported wider first-half losses on lower...